{"grounding": "Apoptosis is central for the maintenance of health. In the immune system, apoptosis guarantees proper development of immune cells and shutdown of immune reactions by the coordinated elimination of activated immune cells. Limitation of the life span of granulocytes is important, as overactivation of these cells is associated with chronic inflammation and collateral tissue damage. Consequently, targeted induction of granulocyte apoptosis may be beneficial in the course of respective immune disorders. Anti-inflammatory drugs such as glucocorticoids and monoclonal antibodies against IL-5R\u03b1 exert their function in part by triggering eosinophil apoptosis. Agonistic antibodies targeting Siglec-8 or death receptors are tested (pre)clinically. Moreover, a new class of inhibitors targeting antiapoptotic BCL-2 proteins shows great promise for anticancer treatments. Because of their specificity and tolerable side effects, these so-called BH3 mimetics may be worthwhile to evaluate in inflammatory disorders. Here, we review past and recent data on pharmacological apoptosis induction of granulocytes and highlight respective therapeutic potential.", "generated_text": "This study investigates the pharmacological induction of granulocyte cell death as a novel therapeutic strategy for various inflammatory and autoimmune diseases. Granulocytes, comprising neutrophils, eosinophils, and basophils, play a crucial role in immune responses, but their dysregulation can lead to tissue damage and disease progression. We review the current literature on the mechanisms of granulocyte apoptosis and the potential therapeutic applications of pharmacological inducers of granulocyte cell death. Our analysis reveals that targeting granulocytes with specific pharmacological agents may offer a promising approach for treating conditions characterized by excessive granulocyte activation, such as asthma, chronic obstructive pulmonary disease, and autoimmune disorders. The induction of granulocyte apoptosis may also provide a novel strategy for preventing graft rejection and reducing inflammation in surgical settings. Further research is needed to fully explore the therapeutic potential of granulocyte apoptosis induction and to identify safe and effective pharmacological agents for this purpose.", "label": 1}